Previous research efforts have focused mainly on the impact of UVB radiation (∼295–315 nm) on human health, which is connected to chronic skin inflammation, skin aging, and melanoma.
8 Ultraviolet B-related ocular pathologies include cataract, conjunctival melanoma, macular degeneration,
9–11 and pterygium, a benign tumor of the conjunctiva.
12 In contrast, UVA radiation (315–400 nm) carries lower energy and, therefore, is considered to have a less damaging effect. Nonetheless, recent reports demonstrate that UVA, too, is a major inducer of corneal photo-aging by causing changes to the stromal extracellular matrix.
13 Also, UVA is a regulator of immunity, since it may induce systemic immunomodulation by reducing the numbers of epidermal Langerhans cells as well as upregulating mucosal immunoglobulin A in the intestine.
14 Furthermore, UVA has been shown to modulate contact hypersensitivity of the skin and intestines by affecting mast cells.
15 Ultraviolet A is used clinically in corneal cross-linking for the treatment of keratoconus and other corneal-ecstatic disorders. In these treatments, adverse effects in the limbal epithelial cell compartment have been reported. Specifically, it has been found that UVA treatment promoted the upregulation of genes connected to apoptosis,
16 while signs of oxidative damage were found in basal limbal epithelial cells positive for the putative stem cell marker P63α, thus suggesting a link of UVA to an impairment of the limbal stem cell population.
17